151 related articles for article (PubMed ID: 16944758)
1. [Remission in T-cell prolymphocytic leukemia during the FMC treatment course].
Valiev TT; Vinogradova IuE; Chernova NG; Mar'in DS; Volkova IaK; Petrova VI; Bulanov AIu; Kalinin NN; Semenova EA; Gretsov EM; Kravchenko SK; Kremenetskaia AM; Vorob'ev AI
Ter Arkh; 2006; 78(7):87-90. PubMed ID: 16944758
[No Abstract] [Full Text] [Related]
2. A combination therapy with fludarabine, mitoxantrone and rituximab induces complete immunophenotypical remission in B-cell prolymphocytic leukaemia.
Tempescul A; Feuerbach J; Ianotto JC; Dalbies F; Marion V; Le Bris MJ; De Braekeleer M; Berthou C
Ann Hematol; 2009 Jan; 88(1):85-8. PubMed ID: 18654781
[No Abstract] [Full Text] [Related]
3. A brief intensive chemotherapy in T-prolymphocytic leukemia.
Billio A; Pescosta N; Rosanelli C; Fabris P; Coser P
Haematologica; 2000 Apr; 85(4):438-9. PubMed ID: 10756378
[No Abstract] [Full Text] [Related]
4. Sequential chemoimmunotherapy of fludarabine, mitoxantrone, and cyclophosphamide induction followed by alemtuzumab consolidation is effective in T-cell prolymphocytic leukemia.
Hopfinger G; Busch R; Pflug N; Weit N; Westermann A; Fink AM; Cramer P; Reinart N; Winkler D; Fingerle-Rowson G; Stilgenbauer S; Döhner H; Kandler G; Eichhorst B; Hallek M; Herling M
Cancer; 2013 Jun; 119(12):2258-67. PubMed ID: 23512246
[TBL] [Abstract][Full Text] [Related]
5. Allogeneic stem cell transplantation after reduced-intensity conditioning in a patient with T-cell prolymphocytic leukemia: graft-versus-tumor effect and long-term remission.
de Lavallade H; Faucher C; Fürst S; El-Cheikh J; Vey N; Coso D; Bouabdallah R; Stoppa AM; Gastaut JA; Blaise D; Mohty M
Bone Marrow Transplant; 2006 Apr; 37(7):709-10. PubMed ID: 16474410
[No Abstract] [Full Text] [Related]
6. Fludarabine, mitoxantrone and dexamethasone as first-line treatment for T-cell large granular lymphocyte leukemia.
Tse E; Chan JC; Pang A; Au WY; Leung AY; Lam CC; Kwong YL
Leukemia; 2007 Oct; 21(10):2225-6. PubMed ID: 17525720
[No Abstract] [Full Text] [Related]
7. Allogeneic bone marrow transplantation in a patient with T-prolymphocytic leukemia with small-intestinal involvement.
Murase K; Matsunaga T; Sato T; Kuribayashi K; Kogawa K; Kawano Y; Okamoto T; Takayama T; Watanabe H; Niitsu Y; Hirayama Y
Int J Clin Oncol; 2003 Dec; 8(6):391-4. PubMed ID: 14663643
[TBL] [Abstract][Full Text] [Related]
8. Unusual lymphoma manifestations: case 3. CD8+ T-cell prolymphocytic leukemia.
Nakajima H; Oki M; Ando K
J Clin Oncol; 2004 Feb; 22(3):560-2. PubMed ID: 14752080
[No Abstract] [Full Text] [Related]
9. Leukemic pleural effusion in B-cell prolymphocytic leukemia.
Andrieu V; Encaoua R; Carbon C; Couvelard A; Grange MJ
Hematol Cell Ther; 1998 Dec; 40(6):275-8. PubMed ID: 9924927
[TBL] [Abstract][Full Text] [Related]
10. Changing the way we think about chronic lymphocytic leukemia.
Lin TS; Grever MR; Byrd JC
J Clin Oncol; 2005 Jun; 23(18):4009-12. PubMed ID: 15767640
[No Abstract] [Full Text] [Related]
11. Sustained response of refractory prolymphocytic leukemia to fludarabine.
Sporn JR
Acta Haematol; 1991; 85(4):209-11. PubMed ID: 1853684
[TBL] [Abstract][Full Text] [Related]
12. Prolymphocytic leukemia: diagnosis and treatment. A case report.
Akin C; Hansen P; Janckila A
J Ky Med Assoc; 1997 Nov; 95(11):465-7. PubMed ID: 9392933
[TBL] [Abstract][Full Text] [Related]
13. [Prolymphocytic leukemia].
Jantunen E; Lahtinen R
Duodecim; 1992; 108(10):955-9. PubMed ID: 1366274
[No Abstract] [Full Text] [Related]
14. Clinical challenges in chronic lymphocytic leukemia.
O'Brien S
Semin Hematol; 1998 Jul; 35(3 Suppl 3):22-6. PubMed ID: 9685176
[No Abstract] [Full Text] [Related]
15. Conjunctival involvement with T-cell prolymphocytic leukemia: report of a case and review of the literature.
Lee SS; Robinson MR; Morris JC; Mirtsching BC; Shen D; Chan CC
Surv Ophthalmol; 2004; 49(5):525-36. PubMed ID: 15325197
[TBL] [Abstract][Full Text] [Related]
16. Low-dose thalidomide in combination with oral fludarabine and cyclophosphamide is ineffective in heavily pretreated patients with chronic lymphocytic leukemia.
Giannopoulos K; Dmoszyńska A; Roliński J
Leuk Res; 2007 Mar; 31(3):411-2. PubMed ID: 16978694
[No Abstract] [Full Text] [Related]
17. Fludarabine, cyclophosphamide, and mitoxantrone as initial therapy of chronic lymphocytic leukemia: high response rate and disease eradication.
Bosch F; Ferrer A; Villamor N; González M; Briones J; González-Barca E; Abella E; Gardella S; Escoda L; Pérez-Ceballos E; Asensi A; Sayas MJ; Font L; Altés A; Muntañola A; Bertazzoni P; Rozman M; Aymerich M; Giné E; Montserrat E
Clin Cancer Res; 2008 Jan; 14(1):155-61. PubMed ID: 18172266
[TBL] [Abstract][Full Text] [Related]
18. Frontline therapy for chronic lymphocytic leukemia: the dilemma continues.
Nabhan C
Clin Cancer Res; 2008 Jul; 14(13):4353. PubMed ID: 18594019
[No Abstract] [Full Text] [Related]
19. [Use of fludarabin in conjunction with other cytostatics in the treatment of non-Hodgkin lymphoma resistant to standard chemotherapy].
Gershanovich ML; Tikhonova VV
Vopr Onkol; 2004; 50(5):602-4. PubMed ID: 15715106
[TBL] [Abstract][Full Text] [Related]
20. Complete remission in T-cell prolymphocytic leukemia with 2-chlorodeoxyadenosine.
Palomera L; Domingo JM; Agulló JA; Soledad Romero M
J Clin Oncol; 1995 May; 13(5):1284-5. PubMed ID: 7738636
[No Abstract] [Full Text] [Related]
[Next] [New Search]
